Literature DB >> 9344886

Pharmacokinetics and metabolism of dichloroacetate in the F344 rat after prior administration in drinking water.

A Gonzalez-Leon1, I R Schultz, G Xu, R J Bull.   

Abstract

The effect of prior administration of dichloroacetate (DCA) in drinking water on the pharmacokinetics of DCA in male F344 rats was studied. Rats were provided with DCA in their drinking water at 0.2 and 2.0 g/liter for 14 days and then challenged with iv bolus iv or gavage doses of [14C1,2]DCA, 16 hr after pretreatment withdrawal. The blood concentration-time profiles of DCA and the disposition of 14C was characterized and compared with controls. The effect of pretreatment on the in vitro metabolism of DCA in hepatic cytosol was also evaluated. Pretreatment caused a significant increase in the blood concentration and AUC0-->infinity of DCA (433.3 versus 2406 microg ml-1 hr). Pharmacokinetic analysis indicated that pretreatment significantly decreased total body clearance (267.4 versus 42.7 ml hr-1 kg-1), which was largely due to decreased metabolism since only modest differences in the urinary clearance of DCA were observed. Pretreatment significantly decreased the formation of 14CO2 after both iv and oral doses of [14C]DCA. The decrease in CO2 formation was also observed after pretreatment with DCA at 0.2 g/liter. Pretreatment also increased the urinary elimination of DCA and several metabolites, particularly glycolate. The in vitro experiments demonstrated that DCA pretreatment inhibited the conversion of DCA to glyoxylate, oxalate, and glycolate in hepatic cytosol. These results indicate that DCA has an auto-inhibitory effect on its metabolism and that pharmacokinetic studies using single doses in naïve rats will underestimate the concentration of DCA at the target tissue during chronic or repeated exposures. Copyright 1997 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9344886     DOI: 10.1006/taap.1997.8232

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  10 in total

Review 1.  Therapeutic applications of dichloroacetate and the role of glutathione transferase zeta-1.

Authors:  Margaret O James; Stephan C Jahn; Guo Zhong; Marci G Smeltz; Zhiwei Hu; Peter W Stacpoole
Journal:  Pharmacol Ther       Date:  2016-10-19       Impact factor: 12.310

2.  Toxicity and carcinogenicity of the water disinfection byproduct, dibromoacetic acid, in rats and mice.

Authors:  Ronald L Melnick; Abraham Nyska; Paul M Foster; Joseph H Roycroft; Grace E Kissling
Journal:  Toxicology       Date:  2006-12-08       Impact factor: 4.221

3.  Effects of Multiple Doses of Dichloroacetate on GSTZ1 Expression and Activity in Liver and Extrahepatic Tissues of Young and Adult Rats.

Authors:  Edwin J Squirewell; Marci G Smeltz; Laura Rowland-Faux; Lloyd P Horne; Peter W Stacpoole; Margaret O James
Journal:  Drug Metab Dispos       Date:  2020-09-01       Impact factor: 3.922

4.  Physiologically based pharmacokinetic modeling of dibromoacetic acid in F344 rats.

Authors:  Jessica L Matthews; Irvin R Schultz; Michael R Easterling; Ronald L Melnick
Journal:  Toxicol Appl Pharmacol       Date:  2010-01-04       Impact factor: 4.219

Review 5.  Human variability and susceptibility to trichloroethylene.

Authors:  G M Pastino; W Y Yap; M Carroquino
Journal:  Environ Health Perspect       Date:  2000-05       Impact factor: 9.031

Review 6.  Issues in the pharmacokinetics of trichloroethylene and its metabolites.

Authors:  Weihsueh A Chiu; Miles S Okino; John C Lipscomb; Marina V Evans
Journal:  Environ Health Perspect       Date:  2006-09       Impact factor: 9.031

Review 7.  Mode of action of liver tumor induction by trichloroethylene and its metabolites, trichloroacetate and dichloroacetate.

Authors:  R J Bull
Journal:  Environ Health Perspect       Date:  2000-05       Impact factor: 9.031

8.  Gender-Related Effect of Sodium Dichloroacetate on the Number of Hassall's Corpuscles and RNA NKCC1 Expression in Rat Thymus.

Authors:  Jūratė Stanevičiūtė; Milda Juknevičienė; Ingrida Balnytė; Angelija Valančiūtė; Vaiva Lesauskaitė; Julija Fadejeva; Rimantas Stakauskas; Donatas Stakišaitis
Journal:  Biomed Res Int       Date:  2019-04-24       Impact factor: 3.411

Review 9.  The Importance of Gender-Related Anticancer Research on Mitochondrial Regulator Sodium Dichloroacetate in Preclinical Studies In Vivo.

Authors:  Donatas Stakišaitis; Milda Juknevičienė; Eligija Damanskienė; Angelija Valančiūtė; Ingrida Balnytė; Marta Maria Alonso
Journal:  Cancers (Basel)       Date:  2019-08-20       Impact factor: 6.639

10.  Low-dose pharmacokinetics and oral bioavailability of dichloroacetate in naive and GST-zeta-depleted rats.

Authors:  Shakil A Saghir; Irvin R Schultz
Journal:  Environ Health Perspect       Date:  2002-08       Impact factor: 9.031

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.